Author:
Chen Xuejun,Wang Shanshan,Wu Jie,Duan Shuwei,Wang Xiaolong,Hong Xiaoxuan,Han Xiaolu,Li Conghui,Kang Dongzhou,Wang Zengming,Zheng Aiping
Abstract
Three-dimensional (3D) printing is an additive manufacturing technique that creates objects under computer control. Owing to the rapid advancement of science and technology, 3D printing technology has been widely utilized in processing and manufacturing but rarely used in the pharmaceutical field. The first commercial form of Spritam® immediate-release tablet was approved by FDA in 2015, which promoted the advancement of 3D printing technology in pharmaceutical development. Three-dimensional printing technology is able to meet individual treatment demands with customized size, shape, and release rate, which overcomes the difficulties of traditional pharmaceutical technology. This paper intends to discuss the critical process parameters of binder jet 3D printing technology, list its application in pharmaceutical manufacturing in recent years, summarize the still-open questions, and demonstrate its great potential in the pharmaceutical industry.
Funder
National Natural Science Foundation of China
Beijing Natural Science Foundation of China
Reference99 articles.
1. The Shape of Things to Come: Emerging Applications of 3D Printing in Healthcare;3D Printing of Pharmaceuticals,2018
2. Medical Applications for 3D Printing: Current and Projected Uses;Pharm. Ther.,2014
3. 3D Printing Technology; Methods, Biomedical Applications, Future Opportunities and Trends;J. Mater. Res. Technol.,2021
4. Additive Manufacturing: Technology, Applications and Research Needs;Front. Mech. Eng.,2013
5. The New 3D Printing: Researchers Are Developing Techniques to Print Faster, Bigger and Weirder;Nature,2020
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献